Abstract

Wood-based cellulose nanofibrils (CNF) offer an excellent scaffold for drug-delivery formulation development. However, toxicity and haemocompatibility of the drug carrier is always an important issue. In this study, toxicity-related issues of CNF were addressed. Different doses of CNF were orally administered to Drosophila and different tests like the developmental cycle, trypan blue exclusion assay, larva crawling assay, thermal sensitivity assay, cold sensitivity assay, larval light preference test, climbing behaviour, nitroblue tetrazolium (NBT) reduction assay, adult phenotype, and adult weight were conducted to observe the impact on its development and behaviour. A haemocompatibility assay was done on the blood taken from healthy Wistar rats. In Drosophila, the abnormalities in larval development and behaviour were observed in the behavioural assays. However, the cytotoxic effect could not be confirmed by the gut staining and level of reactive oxygen species. The larvae developed into an adult without any abnormality in the phenotype. The CNF did cause loss of weight in the adult flies and did not cause much toxicity within the body since there was no phenotypic defect. Hemolysis data also suggested that CNF was safe at lower doses, as the data was well within acceptable limits. All these results suggest that cellulose nanofibres have no significant cytotoxic effects on Drosophila. However, the developmental and behavioural abnormalities suggest that CNF may act as a behavioural teratogen.

Highlights

  • Plant-based polymers offer an environmentally benign alternative to inorganic materials for biomaterial applications [1,2,3,4,5]

  • We have addressed the toxicity concerns of cellulose nanofibrils (CNF) by an in vivo investigation using Drosophila melanogaster as a model organism and haemocompatibility using the blood from healthy Wistar rats

  • CNFs are commonly produced by mechanical methods

Read more

Summary

Introduction

Plant-based polymers offer an environmentally benign alternative to inorganic materials for biomaterial applications [1,2,3,4,5]. Most of the cellulose in nature is produced by plants, where it serves as the main component of the cell wall. It is found in some tunicates, bacteria and several algal species [6]. The application of plant-based cellulose derivatives in biomedical applications is not new They have been traditionally used as an excipient in tablets, in capsule shell preparation, as the formulation component of medicated patches, formulation coating, and many others [11,12,13,14]. The nano-sized cellulose fibrils have created new opportunities for developing new formulations due to a large surface area and better properties

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call